•1 min read•from Science News
A new pancreatic cancer pill may be a game changer for patients
Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.
Want to read more?
Check out the full article on the original site
Tagged with
#pancreatic cancer
#Daraxonrasib
#survival time
#cancer protein
#cell growth
#patients
#disease
#treatment
#therapy
#game changer
#novel drug
#oncology
#clinical trials
#molecular targeting
#cancer research
#therapeutic strategy
#patient outcomes
#biomarkers
#efficacy
#adverse effects